Cannabinoids reduce ErbB2-driven breast cancer progression through Akt inhibition. - Wikidata - wikimedia - TriplyDB

Cannabinoids reduce ErbB2-driven breast cancer progression through Akt inhibition.

Cannabinoids reduce ErbB2-driven breast cancer progression through Akt inhibition.

http://www.wikidata.org/entity/Q34049715

about

Non-THC cannabinoids inhibit prostate carcinoma growth in vitro and in vivo: pro-apoptotic effects and underlying mechanisms Endocannabinoids as Guardians of Metastasis Cannabinoids as therapeutic agents in cancer: current status and future implications Cannabinoids, endocannabinoids, and cancer Preclinical and Clinical Assessment of Cannabinoids as Anti-Cancer Agents Crosstalk between chemokine receptor CXCR4 and cannabinoid receptor CB2 in modulating breast cancer growth and invasion Minireview: recent developments in the physiology and pathology of the lysophosphatidylinositol-sensitive receptor GPR55.Anandamide inhibits breast tumor-induced angiogenesis O-1602, an atypical cannabinoid, inhibits tumor growth in colitis-associated colon cancer through multiple mechanisms.Targeting multiple cannabinoid anti-tumour pathways with a resorcinol derivative leads to inhibition of advanced stages of breast cancer.Cannabinoid receptors, CB1 and CB2, as novel targets for inhibition of non-small cell lung cancer growth and metastasis.The Antitumor Activity of Plant-Derived Non-Psychoactive Cannabinoids.Regulation of circulating endocannabinoids associated with cancer and metastases in mice and humans.Expression and functional relevance of cannabinoid receptor 1 in Hodgkin lymphoma.Monoacylglycerol lipase exerts dual control over endocannabinoid and fatty acid pathways to support prostate cancer.The endocannabinoid system and cancer: therapeutic implication.Cannabinoids receptor type 2, CB2, expression correlates with human colon cancer progression and predicts patient survival.Latest advances in novel cannabinoid CB(2) ligands for drug abuse and their therapeutic potential.Cannabinoids induce pancreatic β-cell death by directly inhibiting insulin receptor activation.Disease modification of breast cancer-induced bone remodeling by cannabinoid 2 receptor agonists.Modulation of breast cancer cell viability by a cannabinoid receptor 2 agonist, JWH-015, is calcium dependent.Critical appraisal of the potential use of cannabinoids in cancer management.The endocannabinoid system and sex steroid hormone-dependent cancers.Update on the endocannabinoid system as an anticancer target.Off-target cannabinoid effects mediated by GPR55.Receptor-dependent and receptor-independent endocannabinoid signaling: a therapeutic target for regulation of cancer growth.Selected terpenoids from medicinal plants modulate endoplasmic reticulum stress in metabolic disorders.Delta(9) -tetrahydrocannabinol and cannabidiol as potential curative agents for cancer: A critical examination of the preclinical literature.The evolving role of the endocannabinoid system in gynaecological cancer.Comprehensive Review of Medicinal Marijuana, Cannabinoids, and Therapeutic Implications in Medicine and Headache: What a Long Strange Trip It's Been ….Antitumorigenic targets of cannabinoids - current status and implications.Role of cannabinoid receptor CB2 in HER2 pro-oncogenic signaling in breast cancer.Phyto-, endo- and synthetic cannabinoids: promising chemotherapeutic agents in the treatment of breast and prostate carcinomas.Cannabinoid signaling in health and disease.Cannabinoid receptor 2 as a novel target for promotion of renal cell carcinoma prognosis and progression.Multilayer photodynamic therapy for highly effective and safe cancer treatment.INSIGHT ON THE IMPACT OF ENDOCANNABINOID SYSTEM IN CANCER: A REVIEW.

P2860

Q24622202-21172463-06B0-4991-B33C-AC7F80A27823 Q26766163-14323E67-8329-47DF-9B45-F0AADC29CB5D Q26866298-6D6DC2DE-1B5F-4B26-A8D1-C41EC921869B Q27694715-B1F25103-FCE4-40EA-AEEC-FC9AD385DF8C Q28075903-A714148D-5BF8-4ACD-81DD-40088AC4C490 Q28476823-D8532E93-CA70-4D50-9F2A-360B1F98061B Q33636763-6A4C27A1-4BB4-429E-B7C9-E45F1100FB5E Q34074335-58AFE7D6-D37C-42CD-8B1F-047C36F8B924 Q34298903-4C258171-1A5B-4CD5-8A3D-873F920E6993 Q34402827-61DD36A1-7A4B-415D-9C15-44305FDCC16E Q34513406-98EB2D9B-E4BE-40F6-A95A-AF212CC9A330 Q34669534-1C4F0797-8CD8-473D-A342-5B0C4EF9D14D Q34781231-46DE592B-1BAC-4714-81ED-247C83002E75 Q35069709-B9EBEF78-056E-4D97-A5FE-8D59285171EF Q35146525-BB94A2DA-8B15-466D-99D1-1A672D53FE43 Q35193299-3F906411-943B-4B25-BEF1-B7C094024A2F Q35238992-733FD3C2-6737-4147-A67F-B059612B321B Q36408464-9BF99944-7284-485F-9D98-450EC1A4191D Q36473356-F84B9FAD-08FD-4495-973A-622B0312679D Q36558056-F0D11E1B-D885-4A01-93F6-A2A2F08E400C Q36843205-25843B7A-1BA8-4E31-B061-F64E45E72C93 Q37164208-0D355E32-475E-4741-99ED-005AC144E6C3 Q37393042-1E353640-FB8E-4626-BEE7-2B8505EDB78A Q37829751-D5B11DB5-E3E4-47AA-8A74-6B604D9D40D5 Q37995375-095C2E99-D865-4C74-82B5-616F4EC4A1BD Q38052298-F0EE0CB5-94AC-4149-877D-23765A66E523 Q38211378-23B273D6-1293-4654-8288-9F69870337B2 Q38351132-A01B95A9-9D4C-4380-8B44-C23C0105437B Q38469671-4AD3226D-4AA9-4F08-827E-7238508D6A65 Q38503842-D0CCA442-8FA7-4AA8-99AD-760765C7B242 Q38806270-F9B5790C-7798-4D17-9689-0602E0CEED48 Q38889500-C3775ACE-C7CB-42DE-9D7C-64C4886850F4 Q38955546-0C847262-779A-4AA4-95A1-AE2DB5C8290E Q39163671-3D150604-11EE-4086-912F-A1BE9F760591 Q47673750-5828E89E-A59F-4BA2-9BB4-349879A86167 Q50675905-FF459A25-DA44-49D3-925B-CA363DAFC809 Q52583978-9CDB2BD2-FCD6-4FE8-9E34-E696C8A4DFB5

P2860

Cannabinoids reduce ErbB2-driven breast cancer progression through Akt inhibition.

http://www.wikidata.org/entity/Q34049715

description

2010 nî lūn-bûn

@nan

2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Cannabinoids reduce ErbB2-driven breast cancer progression through Akt inhibition.

@ast

Cannabinoids reduce ErbB2-driven breast cancer progression through Akt inhibition.

@en

Cannabinoids reduce ErbB2-driven breast cancer progression through Akt inhibition.

@nl

type

label

Cannabinoids reduce ErbB2-driven breast cancer progression through Akt inhibition.

@ast

Cannabinoids reduce ErbB2-driven breast cancer progression through Akt inhibition.

@en

Cannabinoids reduce ErbB2-driven breast cancer progression through Akt inhibition.

@nl

prefLabel

Cannabinoids reduce ErbB2-driven breast cancer progression through Akt inhibition.

@ast

Cannabinoids reduce ErbB2-driven breast cancer progression through Akt inhibition.

@en

Cannabinoids reduce ErbB2-driven breast cancer progression through Akt inhibition.

@nl

P1433

Q34049715-5C47B322-8E60-4DB7-A71F-51CA0F5260EE

P1476

Q34049715-079B81D4-5405-41A3-BD4A-DFAF7619740B

P2093

Q34049715-5F87F58B-5AEF-4042-BF14-75F8DFB01AF5

Q34049715-7183B957-D13E-4719-A58B-BAF02843E763

Q34049715-A1A4409D-01E0-48A9-98AC-42B31BF2FC58

Q34049715-B9AF8EC4-E45E-479D-8F0B-28AC045E1DC0

Q34049715-B9C93A7D-6726-485E-93E2-C16ED6F9408C

Q34049715-BD81ADF4-4B88-4066-B40F-4850E7520A1B

Q34049715-E9116407-C5B6-410C-83FB-34CC19F3FD68

P2860

Q34049715-00759FF3-EE0D-4160-B055-97E29F81DEB0

Q34049715-076611EB-7887-4BF5-8338-7A99B7A19445

Q34049715-0FF8FF82-AFB3-4BBA-8FDE-242F9ACC8FA2

Q34049715-26B4A6AF-AF5D-4099-8A76-357B555FBDC7

Q34049715-285B388F-3770-4692-AE72-9E3B565A2231

Q34049715-2C257AD0-71F0-43CE-8FD8-20C4EA5D0C4E

Q34049715-3D45ED3C-2BA0-4DE3-B5B2-D9F86B2928A5

Q34049715-47A5C909-C82F-4D63-8A2D-E622CC35CA72

Q34049715-4C8A1DC4-466A-4742-9740-927755FF6A66

Q34049715-4CB7F616-A59E-4692-A5CA-FBBCB999DDD0

P2888

Q34049715-5036613A-4080-41D5-AC4B-6F475F9D04E6

P304

Q34049715-DF65AB2C-88B0-4982-9E55-A2C78F656DE4

P31

Q34049715-0D1F12FA-C03C-41BA-BB61-5CB9DE71BE90

P356

Q34049715-BC56B288-2151-47A9-B728-187A7A7C041F

P478

Q34049715-7C13D260-35D0-40D3-8A44-17CA645A1641

P50

Q34049715-0CDD2907-5586-412C-A53C-155FEBCB429F

Q34049715-0CEA055E-840A-46F8-813A-DBE9C6CC6D81

Q34049715-2D97A06B-E96F-470A-8144-BBC2BB24EB60

Q34049715-5B264818-213A-40B7-87FC-4E03CEDFE38C

Q34049715-84993685-7F47-4B52-999F-FD16215401EF

P577

Q34049715-BFF3181B-60D5-42A8-AE0C-4D5CCC4CEFD8

P5875

Q34049715-08304F73-8C65-417C-A7CC-A6305CD00CC8

P6179

Q34049715-3ABBEFD9-7EAC-471E-87AC-794865F47A5C

P698

Q34049715-9EEC01EA-291B-4AB2-9382-5C08A202A4DB

P921

Q34049715-80BFADA0-D80A-4F79-8F9B-4FB4602A9BEA

P932

Q34049715-A1A5E9F7-2521-4BCD-A2AD-83BFC2FA6FB3

P356

1476-4598-9-196

P1433

Molecular Cancer

P1476

Cannabinoids reduce ErbB2-driven breast cancer progression through Akt inhibition

@en

P2093

Clara Andradas

http://www.w3.org/2001/XMLSchema#string

Emilia Mira

http://www.w3.org/2001/XMLSchema#string

Isabel García-Real

http://www.w3.org/2001/XMLSchema#string

José Palacios

http://www.w3.org/2001/XMLSchema#string

Juana M Flores

http://www.w3.org/2001/XMLSchema#string

Manuel Guzmán

http://www.w3.org/2001/XMLSchema#string

Santos Mañes

http://www.w3.org/2001/XMLSchema#string

P2860

AKT/PKB signaling: navigating downstream

Antitumor activity of plant cannabinoids with emphasis on the effect of cannabidiol on human breast carcinoma

Overexpression of matrix-metalloproteinase-9 in human breast cancer: a potential favourable indicator in node-negative patients

Expression of the neu protooncogene in the mammary epithelium of transgenic mice induces metastatic disease.

Genes that mediate breast cancer metastasis to lung

Dissemination and growth of cancer cells in metastatic sites

ERBB receptors and cancer: the complexity of targeted inhibitors

Suppression of nerve growth factor Trk receptors and prolactin receptors by endocannabinoids leads to inhibition of human breast and prostate cancer cell proliferation.

Synthetic cannabinoid receptor agonists inhibit tumor growth and metastasis of breast cancer.

The endogenous cannabinoid anandamide inhibits human breast cancer cell proliferation.

P2888

1476-4598-9-196

P304

196

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1476-4598-9-196

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P50

Cristina Sánchez

Gema Moreno-Bueno

Camilla Cerutti

Maria M Caffarel

Eduardo Pérez-Gómez

P577

2010-07-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

45281051

http://www.w3.org/2001/XMLSchema#string

P6179

1002304640

http://www.w3.org/2001/XMLSchema#string

P698

20649976

http://www.w3.org/2001/XMLSchema#string

P921

P932

2917429

http://www.w3.org/2001/XMLSchema#string